Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-22-002568
Filing Date
2022-03-01
Accepted
2022-03-01 16:55:27
Documents
72
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K axsm-20211231.htm   iXBRL 10-K 3138662
2 EX-23.1 axsm-ex23_1.htm EX-23.1 15338
3 EX-31.1 axsm-ex31_1.htm EX-31.1 19841
4 EX-31.2 axsm-ex31_2.htm EX-31.2 19507
5 EX-32.1 axsm-ex32_1.htm EX-32.1 7177
6 EX-32.2 axsm-ex32_2.htm EX-32.2 7178
7 GRAPHIC img238398520_0.jpg GRAPHIC 240510
8 GRAPHIC img238398520_1.jpg GRAPHIC 289890
  Complete submission text file 0000950170-22-002568.txt   11538834

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT axsm-20211231.xsd EX-101.SCH 61758
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT axsm-20211231_pre.xml EX-101.PRE 375791
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT axsm-20211231_def.xml EX-101.DEF 199927
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT axsm-20211231_cal.xml EX-101.CAL 50198
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT axsm-20211231_lab.xml EX-101.LAB 532267
66 EXTRACTED XBRL INSTANCE DOCUMENT axsm-20211231_htm.xml XML 1771669
Mailing Address 22 CORTLANDT STREET, 16TH FLOOR NEW YORK NY 10007
Business Address 22 CORTLANDT STREET, 16TH FLOOR NEW YORK NY 10007 (212) 332-3241
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

EIN.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37635 | Film No.: 22699244
SIC: 2834 Pharmaceutical Preparations